MEI Pharma will present at the HC Wainwright Global Investment Conference 2022
SAN DIEGO, May 17, 2022--(BUSINESS WIRE)--MEI Pharma, Inc. (NASDAQ:MEIP), a late-stage pharmaceutical company focused on advancing novel cancer therapies, today announced its participation in the 2022 HC Wainwright Global Investment…